Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan M Zenilman

Showing results (101-110 of 111) with videos related to

Pageof 12
Sort By:
Cancer Causes & Control : CCC|July 20, 2012
Prospective study of cytomegalovirus serostatus and prostate cancer risk in the Prostate Cancer Prevention TrialSiobhan Sutcliffe, Cathee Till, Charlotte A Gaydos, et al.
The Prostate|August 23, 2018
Sustained influence of infections on prostate-specific antigen concentration: An analysis of changes over 10 years of follow-upMarvin E Langston, Ratna Pakpahan, Remington L Nevin, et al.
Antimicrobial Agents and Chemotherapy|June 7, 2017
Safety, Tolerability, Systemic Exposure, and Metabolism of CRS3123, a Methionyl-tRNA Synthetase Inhibitor Developed for Treatment of Clostridium difficile, in a Phase 1 StudySeema U Nayak, J McLeod Griffiss, Jeffrey Blumer, et al.
The Prostate|August 4, 2019
Trichomonas vaginalis infection and prostate-specific antigen concentration: Insights into prostate involvement and prostate disease riskMarvin E Langston, Ankita Bhalla, John F Alderete, et al.
International Journal of Cancer|December 19, 2015
Infectious mononucleosis, other infections and prostate-specific antigen concentration as a marker of prostate involvement during infectionSiobhan Sutcliffe, Remington L Nevin, Ratna Pakpahan, et al.
The Prostate|July 14, 2017
Insight into infection-mediated prostate damage: Contrasting patterns of C-reactive protein and prostate-specific antigen levels during infectionMelissa Milbrandt, Anke C Winter, Remington L Nevin, et al.
Medrxiv : the Preprint Server for Health Sciences|February 3, 2021
Comparative performance of multiplex salivary and commercially available serologic assays to detect SARS-CoV-2 IgG and neutralization titersChristopher D Heaney, Nora Pisanic, Pranay R Randad, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|October 25, 2021
Comparative performance of multiplex salivary and commercially available serologic assays to detect SARS-CoV-2 IgG and neutralization titersChristopher D Heaney, Nora Pisanic, Pranay R Randad, et al.
Military Medicine|May 3, 2013
Combat Wound Initiative programAlexander Stojadinovic, Eric Elster, Benjamin K Potter, et al.
Medrxiv : the Preprint Server for Health Sciences|December 21, 2021
Randomized controlled trial transfusing convalescent plasma as post-exposure prophylaxis against SARS-CoV-2 infectionShmuel Shoham, Evan M Bloch, Arturo Casadevall, et al.
Pageof 12

Showing results (101-110 of 111) with videos related to

Sort By:
Pageof 12
Cancer Causes & Control : CCC|July 20, 2012
Prospective study of cytomegalovirus serostatus and prostate cancer risk in the Prostate Cancer Prevention TrialSiobhan Sutcliffe, Cathee Till, Charlotte A Gaydos, et al.
The Prostate|August 23, 2018
Sustained influence of infections on prostate-specific antigen concentration: An analysis of changes over 10 years of follow-upMarvin E Langston, Ratna Pakpahan, Remington L Nevin, et al.
Antimicrobial Agents and Chemotherapy|June 7, 2017
Safety, Tolerability, Systemic Exposure, and Metabolism of CRS3123, a Methionyl-tRNA Synthetase Inhibitor Developed for Treatment of Clostridium difficile, in a Phase 1 StudySeema U Nayak, J McLeod Griffiss, Jeffrey Blumer, et al.
The Prostate|August 4, 2019
Trichomonas vaginalis infection and prostate-specific antigen concentration: Insights into prostate involvement and prostate disease riskMarvin E Langston, Ankita Bhalla, John F Alderete, et al.
International Journal of Cancer|December 19, 2015
Infectious mononucleosis, other infections and prostate-specific antigen concentration as a marker of prostate involvement during infectionSiobhan Sutcliffe, Remington L Nevin, Ratna Pakpahan, et al.
The Prostate|July 14, 2017
Insight into infection-mediated prostate damage: Contrasting patterns of C-reactive protein and prostate-specific antigen levels during infectionMelissa Milbrandt, Anke C Winter, Remington L Nevin, et al.
Medrxiv : the Preprint Server for Health Sciences|February 3, 2021
Comparative performance of multiplex salivary and commercially available serologic assays to detect SARS-CoV-2 IgG and neutralization titersChristopher D Heaney, Nora Pisanic, Pranay R Randad, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|October 25, 2021
Comparative performance of multiplex salivary and commercially available serologic assays to detect SARS-CoV-2 IgG and neutralization titersChristopher D Heaney, Nora Pisanic, Pranay R Randad, et al.
Military Medicine|May 3, 2013
Combat Wound Initiative programAlexander Stojadinovic, Eric Elster, Benjamin K Potter, et al.
Medrxiv : the Preprint Server for Health Sciences|December 21, 2021
Randomized controlled trial transfusing convalescent plasma as post-exposure prophylaxis against SARS-CoV-2 infectionShmuel Shoham, Evan M Bloch, Arturo Casadevall, et al.
Pageof 12